Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Short-term Feasibility Provox Vega 22.5 French

Outcome Description:

Number of participants in whom the voice prosthesis was considered feasible in the short-term with regards to clinical and technical aspects as judged by patient and investigator.

Outcome Time Frame:

3 weeks

Safety Issue:

No

Principal Investigator

Frans JM Hilgers, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

The Netherlands Cancer Institute

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

UD778

NCT ID:

NCT00743262

Start Date:

April 2008

Completion Date:

April 2009

Related Keywords:

• Total Laryngectomy
• laryngectomy
• larynx cancer

Name	Location